Relationship of CD146 expression to activation of circulating T cells:: exploratory studies in healthy donors and patients with connective tissue diseases

Andreas V. Hadjinicolaou; L. Wu; Brian Fang; Pippa A. Watson; Frances C. Hall; Robert Busch

doi:10.1111/cei.12151

Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases

Andreas V. Hadjinicolaou, L. Wu, Brian Fang, Pippa A. Watson, Frances C. Hall, Robert Busch

Research output: Contribution to journal › Article › peer-review

Abstract

The endothelial cell adhesion molecule, CD146, is expressed on ≈ 2% of normal circulating T cells, correlating with T cell activation, endothelial interactions and T helper type 17 (Th17) effector functions. In this study, we have characterized CD146 expression in circulating T cells from healthy controls and patients with stable, well-controlled autoimmune connective tissue diseases (CTDs). In vitro, anti-CD3/anti-CD28 stimulation induced CD146 expression in both CD4 and CD8 T cells. In healthy controls and CTD patients, CD146 was associated with expression of recent and chronic activation markers (CD25(+), OX-40(+), CD69(+), CD27(-)) and was confined to CD45RO(+)/RA(-)/CD28(+) populations within the CD4 subset. Except for CD69, these markers were not associated with CD146 in the CD8 subset. Surprisingly, most CTD patients exhibited no T cell hyperactivation ex vivo. In five of five patients with secondary Sjögren's syndrome circulating T cells appeared activated despite therapy, and CD146 up-regulation, associated with activation markers, was observed both on CD4 and CD8 T cells. There was no association between CD146 and putative pro-atherogenic T cell subsets. In conclusion, the relationship of CD146 expression to T cell activation differs between T cell subsets in healthy subjects and correlates with systemic hyperactivity, where present, in patients with CTDs, as exemplified by the patients with secondary Sjögren's syndrome in this study.

Original language	English
Pages (from-to)	63-88
Journal	CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume	174
Issue number	1
DOIs	https://doi.org/10.1111/cei.12151
Publication status	Published - 2013

Access to Document

10.1111/cei.12151Licence: Unspecified

http://onlinelibrary.wiley.com/doi/10.1111/cei.12151/pdf

Cite this

@article{b80b9498ac7945bdafdc06bb5c852543,

title = "Relationship of CD146 expression to activation of circulating T cells:: exploratory studies in healthy donors and patients with connective tissue diseases",

abstract = "The endothelial cell adhesion molecule, CD146, is expressed on ≈ 2\% of normal circulating T cells, correlating with T cell activation, endothelial interactions and T helper type 17 (Th17) effector functions. In this study, we have characterized CD146 expression in circulating T cells from healthy controls and patients with stable, well-controlled autoimmune connective tissue diseases (CTDs). In vitro, anti-CD3/anti-CD28 stimulation induced CD146 expression in both CD4 and CD8 T cells. In healthy controls and CTD patients, CD146 was associated with expression of recent and chronic activation markers (CD25(+), OX-40(+), CD69(+), CD27(-)) and was confined to CD45RO(+)/RA(-)/CD28(+) populations within the CD4 subset. Except for CD69, these markers were not associated with CD146 in the CD8 subset. Surprisingly, most CTD patients exhibited no T cell hyperactivation ex vivo. In five of five patients with secondary Sj{\"o}gren's syndrome circulating T cells appeared activated despite therapy, and CD146 up-regulation, associated with activation markers, was observed both on CD4 and CD8 T cells. There was no association between CD146 and putative pro-atherogenic T cell subsets. In conclusion, the relationship of CD146 expression to T cell activation differs between T cell subsets in healthy subjects and correlates with systemic hyperactivity, where present, in patients with CTDs, as exemplified by the patients with secondary Sj{\"o}gren's syndrome in this study.",

author = "Hadjinicolaou, \{Andreas V.\} and L. Wu and Brian Fang and Watson, \{Pippa A.\} and Hall, \{Frances C.\} and Robert Busch",

year = "2013",

doi = "10.1111/cei.12151",

language = "English",

volume = "174",

pages = "63--88",

journal = "CLINICAL AND EXPERIMENTAL IMMUNOLOGY",

issn = "0009-9104",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Relationship of CD146 expression to activation of circulating T cells:

T2 - exploratory studies in healthy donors and patients with connective tissue diseases

AU - Hadjinicolaou, Andreas V.

AU - Wu, L.

AU - Fang, Brian

AU - Watson, Pippa A.

AU - Hall, Frances C.

AU - Busch, Robert

PY - 2013

Y1 - 2013

N2 - The endothelial cell adhesion molecule, CD146, is expressed on ≈ 2% of normal circulating T cells, correlating with T cell activation, endothelial interactions and T helper type 17 (Th17) effector functions. In this study, we have characterized CD146 expression in circulating T cells from healthy controls and patients with stable, well-controlled autoimmune connective tissue diseases (CTDs). In vitro, anti-CD3/anti-CD28 stimulation induced CD146 expression in both CD4 and CD8 T cells. In healthy controls and CTD patients, CD146 was associated with expression of recent and chronic activation markers (CD25(+), OX-40(+), CD69(+), CD27(-)) and was confined to CD45RO(+)/RA(-)/CD28(+) populations within the CD4 subset. Except for CD69, these markers were not associated with CD146 in the CD8 subset. Surprisingly, most CTD patients exhibited no T cell hyperactivation ex vivo. In five of five patients with secondary Sjögren's syndrome circulating T cells appeared activated despite therapy, and CD146 up-regulation, associated with activation markers, was observed both on CD4 and CD8 T cells. There was no association between CD146 and putative pro-atherogenic T cell subsets. In conclusion, the relationship of CD146 expression to T cell activation differs between T cell subsets in healthy subjects and correlates with systemic hyperactivity, where present, in patients with CTDs, as exemplified by the patients with secondary Sjögren's syndrome in this study.

AB - The endothelial cell adhesion molecule, CD146, is expressed on ≈ 2% of normal circulating T cells, correlating with T cell activation, endothelial interactions and T helper type 17 (Th17) effector functions. In this study, we have characterized CD146 expression in circulating T cells from healthy controls and patients with stable, well-controlled autoimmune connective tissue diseases (CTDs). In vitro, anti-CD3/anti-CD28 stimulation induced CD146 expression in both CD4 and CD8 T cells. In healthy controls and CTD patients, CD146 was associated with expression of recent and chronic activation markers (CD25(+), OX-40(+), CD69(+), CD27(-)) and was confined to CD45RO(+)/RA(-)/CD28(+) populations within the CD4 subset. Except for CD69, these markers were not associated with CD146 in the CD8 subset. Surprisingly, most CTD patients exhibited no T cell hyperactivation ex vivo. In five of five patients with secondary Sjögren's syndrome circulating T cells appeared activated despite therapy, and CD146 up-regulation, associated with activation markers, was observed both on CD4 and CD8 T cells. There was no association between CD146 and putative pro-atherogenic T cell subsets. In conclusion, the relationship of CD146 expression to T cell activation differs between T cell subsets in healthy subjects and correlates with systemic hyperactivity, where present, in patients with CTDs, as exemplified by the patients with secondary Sjögren's syndrome in this study.

U2 - 10.1111/cei.12151

DO - 10.1111/cei.12151

M3 - Article

SN - 0009-9104

VL - 174

SP - 63

EP - 88

JO - CLINICAL AND EXPERIMENTAL IMMUNOLOGY

JF - CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IS - 1

ER -